RxDoctor Payments Data
★ My doctorsLook up a doctor →

Suad Khalil

Neurology with Special Qualifications in Child Neurology · East Lansing, MINPI 1164738043

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $119,566 of the $145,759 with a category attached, or 82.0%. UCB, Inc. accounts for 67.9% of it on its own, with 39 other manufacturers making up the rest. 2025 is the largest year on record at $70,889, more than ten times the $2,371 reported in 2019. Among neurology with special qualifications in child neurology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$145,759in general payments, 2019–2025

Across 301 payments — averaging $484.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB, Inc.$99K
  • Neurelis, Inc.$39K
  • Acadia Pharmaceuticals Inc$4K
  • Neuropace, Inc.$2K
  • AstraZeneca$232
  • AbbVie$226
  • plus $1K from 34 others
$248,895in research payments, 2019–2025

Across 75 payments — averaging $3318.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$153K
  • H. Lundbeck A S$96K

What the payments were for

  • Consulting fees$3,6002%
  • Speaking & faculty fees$119,56682%
  • Travel & lodging$14,32310%
  • Food & beverage$8,2456%
  • Education$250%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
UCB, Inc.160$99,018
Neurelis, Inc.49$39,037
Acadia Pharmaceuticals Inc6$4,076
Neuropace, Inc.7$1,691
AstraZeneca8$232
AbbVie11$226
Eisai Inc.2$110
Livanova USA, Inc.2$105
Aquestive Therapeutics, Inc.1$103
SK Life Science, Inc.3$75
Jazz Pharmaceuticals Inc.4$73
Pyros Pharmaceuticals, Inc.2$73
Lundbeck LLC3$72
Genentech USA, Inc.4$66
Biogen3$65
Foundation Medicine, Inc.1$56
Sumitomo Pharma America, Inc.3$50
TG Therapeutics, Inc.2$49
Pfizer2$45
Aucta Pharmaceuticals, Inc.2$45
Argenx US, Inc.2$44
Alnylam Pharmaceuticals Inc.1$36
Novartis1$34
Takeda Pharmaceuticals U.S.A., Inc.1$31
Mallinckrodt Hospital Products Inc.1$30
Sunovion Pharmaceuticals Inc.2$30
Dexcom, Inc.1$29
Sanofi-aventis U.S. LLC1$26
Xeris Pharmaceuticals, Inc.1$25
Tandem Diabetes Care, Inc.1$24
Microtransponder, Inc.1$24
Otter Pharmaceuticals, LLC1$21
Catalyst Pharmaceuticals, Inc.1$21
QOL Medical, LLC1$20
Travere Therapeutics, Inc.5$19
Boston Scientific1$19
Otsuka Pharmaceutical Development & Commercialization, Inc.1$16
Amneal Pharmaceuticals LLC1$16
Insulet Corporation1$14
Supernus Pharmaceuticals, Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$145,759 in reported general payments places this provider in the 95th percentile of 62 neurology with special qualifications in child neurology providers in Michigan.

See all neurology with special qualifications in child neurology providers in Michigan →

Other neurology with special qualifications in child neurology in East Lansing

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →